Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hadoux

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Annales D'Endocrinologie|May 9, 2025
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancerChristine Do Cao, Yann Godbert, Stéphane Bardet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkAurelien Fosse, Julien Hadoux, Paul Girot, et al.
European Thyroid Journal|June 20, 2025
Molecular predictive biomarker testing in advanced thyroid cancer - a European consensusAleš Ryška, Jaume Capdevila, Matthias S Dettmer, et al.
Neuroendocrinology|August 4, 2021
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine TumorsPaul Girot, Eric Baudin, Hélène Senellart, et al.
Cancers|November 13, 2021
Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric ExperienceCaroline Touloupas, Matthieu Faron, Julien Hadoux, et al.
Endocrine-Related Cancer|July 13, 2013
Are G3 ENETS neuroendocrine neoplasms heterogeneous?Fritz-Line Vélayoudom-Céphise, Pierre Duvillard, Lydia Foucan, et al.
Annales D'Endocrinologie|October 2, 2022
Pneumocystis pneumonia in patients with Cushing's syndrome: A French multicenter retrospective studyAlexandre Lugat, Hélène Lasolle, Maud François, et al.
Annales D'Endocrinologie|June 20, 2024
Corrigendum to "Pneumocystis pneumoniae in patients with Cushing's syndrome: A French multicentric retrospective study. Annales d'Endocinologie 84 (2022) 37-44]"Alexandre Lugat, Hélène Lasolle, Maud François, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2020
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 StudyJonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Durability of Response With Selpercatinib in Patients With <i>RET</i>-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001Lori J Wirth, Marcia S Brose, Vivek Subbiah, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Annales D'Endocrinologie|May 9, 2025
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancerChristine Do Cao, Yann Godbert, Stéphane Bardet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkAurelien Fosse, Julien Hadoux, Paul Girot, et al.
European Thyroid Journal|June 20, 2025
Molecular predictive biomarker testing in advanced thyroid cancer - a European consensusAleš Ryška, Jaume Capdevila, Matthias S Dettmer, et al.
Neuroendocrinology|August 4, 2021
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine TumorsPaul Girot, Eric Baudin, Hélène Senellart, et al.
Cancers|November 13, 2021
Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric ExperienceCaroline Touloupas, Matthieu Faron, Julien Hadoux, et al.
Endocrine-Related Cancer|July 13, 2013
Are G3 ENETS neuroendocrine neoplasms heterogeneous?Fritz-Line Vélayoudom-Céphise, Pierre Duvillard, Lydia Foucan, et al.
Annales D'Endocrinologie|October 2, 2022
Pneumocystis pneumonia in patients with Cushing's syndrome: A French multicenter retrospective studyAlexandre Lugat, Hélène Lasolle, Maud François, et al.
Annales D'Endocrinologie|June 20, 2024
Corrigendum to "Pneumocystis pneumoniae in patients with Cushing's syndrome: A French multicentric retrospective study. Annales d'Endocinologie 84 (2022) 37-44]"Alexandre Lugat, Hélène Lasolle, Maud François, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2020
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 StudyJonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Durability of Response With Selpercatinib in Patients With <i>RET</i>-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001Lori J Wirth, Marcia S Brose, Vivek Subbiah, et al.
Pageof 12